These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 31220470)
1. Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis. Bonnin M; Fares N; Testoni B; Estornes Y; Weber K; Vanbervliet B; Lefrançois L; Garcia A; Kfoury A; Pez F; Coste I; Saintigny P; Viari A; Lang K; Guey B; Hervieu V; Bancel B; Bartoch B; Durantel D; Renno T; Merle P; Lebecque S J Hepatol; 2019 Oct; 71(4):763-772. PubMed ID: 31220470 [TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients. Chew V; Tow C; Huang C; Bard-Chapeau E; Copeland NG; Jenkins NA; Weber A; Lim KH; Toh HC; Heikenwalder M; Ng IO; Nardin A; Abastado JP J Natl Cancer Inst; 2012 Dec; 104(23):1796-807. PubMed ID: 23197495 [TBL] [Abstract][Full Text] [Related]
3. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis. Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355 [TBL] [Abstract][Full Text] [Related]
4. Yin L; Cai W; Liang Y; Yao J; Wang X; Shen J Aging (Albany NY); 2020 Nov; 13(1):241-261. PubMed ID: 33173017 [TBL] [Abstract][Full Text] [Related]
5. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma. Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058 [No Abstract] [Full Text] [Related]
6. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823 [TBL] [Abstract][Full Text] [Related]
7. TLR3 expression correlates with apoptosis, proliferation and angiogenesis in hepatocellular carcinoma and predicts prognosis. Yuan MM; Xu YY; Chen L; Li XY; Qin J; Shen Y BMC Cancer; 2015 Apr; 15():245. PubMed ID: 25884709 [TBL] [Abstract][Full Text] [Related]
8. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
9. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models. Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046 [TBL] [Abstract][Full Text] [Related]
10. B‑cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma. Kanda M; Sugimoto H; Nomoto S; Oya H; Hibino S; Shimizu D; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y Int J Oncol; 2015 Feb; 46(2):641-8. PubMed ID: 25405901 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma. Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401 [TBL] [Abstract][Full Text] [Related]
12. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation. Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway. Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259 [TBL] [Abstract][Full Text] [Related]
14. Studying the Effect of Downregulating Autophagy-Related Gene LC3 on TLR3 Apoptotic Pathway Mediated by dsRNA in Hepatocellular Carcinoma Cells. Wang G; Zhang M; Li Y; Zhou J; Chen L Cancer Res Treat; 2017 Jan; 49(1):230-245. PubMed ID: 27338037 [TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. Frau M; Feo F; Pascale RM J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis. Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094 [TBL] [Abstract][Full Text] [Related]
17. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival. Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131 [TBL] [Abstract][Full Text] [Related]
18. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
19. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
20. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL. Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]